Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain

By sjmartinez • November 7, 2024

Rodriguez A, Zeng C, Hays RD, Herman PM, Edelen MO. Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain. Qual Life Res. 2024 Nov 6. doi: 10.1007/s11136-024-03826-6. Epub ahead of print. PMID: 39505759.

Tags: General Internal Medicine, health-related quality of life, patient-reported outcomes, PROMIS-16, PROMIS-29 + 2, Publications, Short form validation

Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium

Nguyen T, Koric A, Chang CE, Barul C, Radoi L, Serraino D, Purdue MP, Kelsey KT, McClean MD, Negri E, Edefonti V, Moysich K, Zhang[...]

Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease

Volkmann ER, Wilhalme H, Tashkin DP, Kim GHJ, Goldin J, Haussmann A, Kuwana M, Roth MD, Assassi S. Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial[...]

Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with

Fansiwala K, Sauk JS. Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with IBD. Dig Dis Sci. 2024 Dec 20.[...]